Chile Achieves WHO Verification for Elimination of Leprosy Disease

In a landmark achievement for global health, Chile has become the first country in the Americas to be officially verified by the World Health Organization (WHO) for the elimination of leprosy disease, marking a major milestone in the fight against neglected tropical diseases. This announcement underscores decades of sustained public health efforts and demonstrates that even ancient diseases can be defeated with persistent commitment and robust health systems.

Chile’s verification follows a comprehensive evaluation by the WHO and the Pan American Health Organization (PAHO), which confirmed that the country has not reported a locally transmitted case of leprosy disease for more than three decades. The last known locally acquired infection occurred in 1993, and since then, the nation has maintained vigilant surveillance and reporting systems. This historic recognition makes Chile not only the first in the Americas but also the second worldwide to achieve such a status, after another pioneering country previously attained this feat.

During an official verification ceremony in Santiago, health officials celebrated the achievement of eliminating leprosy as a public health problem. The WHO Director?General emphasized that Chile’s success illustrates what political will, science, and coordinated action can accomplish, especially against diseases that have long haunted vulnerable communities. This achievement sends a powerful message across the region and beyond, reinforcing that tackling chronic infectious diseases is possible with determined public health strategies.

Health experts note that leprosy disease, also known as Hansen’s disease, is a chronic infectious condition caused by the bacterium Mycobacterium leprae. It primarily targets the skin, peripheral nerves, mucous membranes of the upper respiratory tract, and eyes. If left untreated, the infection can lead to serious nerve damage, irreversible disability, and profound social stigma. However, with timely leprosy treatment using multidrug therapy (MDT), leprosy is fully curable, and complications can be prevented.

Chile’s journey to elimination was neither accidental nor swift. Rather, it was built on a foundation of strong surveillance, mandatory reporting, continuous clinical readiness, and integrated health services that never allowed the disease to drop off the national public health agenda. Even as the number of reported cases dwindled, Chile ensured that its health professionals were trained and prepared to detect and manage any sporadic case that might arise.

A critical component of Chile’s success was the uninterrupted access to MDT, supported by international partnerships led by PAHO and WHO. Since 1995, a continuous supply of treatment, combined with national delivery systems, ensured that patients received effective therapy, which in turn helped interrupt transmission and prevent disability. This sustained access was facilitated through collaborations with global partners committed to eliminating neglected diseases.

Beyond treatment access, Chile’s legal and social frameworks strengthened the impact of its public health strategy. Legislation that protects human rights and promotes social inclusion helped ensure that people affected by leprosy disease could access care without fear of discrimination or exclusion. Such measures also bolstered public trust and encouraged individuals to seek early diagnosis and treatment, reinforcing disease control efforts.

The verification also reflects coordinated cross-sector collaboration. National health authorities worked closely with regional and international agencies to align surveillance with global standards. Laboratory capacity was enhanced, and clinical expertise was maintained even in a low-incidence context where health professionals seldom encounter the disease. These efforts ensured that Chile’s health system remained capable of responding effectively to any new case.

Looking forward, WHO continues to urge Chile to sustain sensitive surveillance systems, retain clinical expertise, and report any new cases promptly. In addition, Chile has been encouraged to designate a national leprosy referral center to further strengthen institutional memory and readiness. These steps acknowledge that elimination does not mean eradication; rather, it signifies a health system’s capacity to detect and respond should cases appear, including those acquired outside the country.

Chile’s milestone also serves as a regional blueprint for other countries striving to eliminate leprosy. It highlights the importance of long-term political commitment, resilient health infrastructure, and community engagement. By demonstrating that chronic infectious diseases can be overcome, Chile’s achievement offers both inspiration and practical lessons for public health practitioners worldwide.

The verification of leprosy elimination in Chile also contributes to global goals outlined in the WHO’s “Towards Zero Leprosy” strategy and PAHO’s Disease Elimination Initiative, which aim to reduce the burden of neglected tropical diseases by 2030. With more than 200,000 new cases still reported annually in over 120 countries, the fight against leprosy continues, but Chile’s success reinforces that progress is possible and that a future free from this ancient disease is within reach.